To determine the incidence of genetic heterogeneity in primary prostat
e cancer, we have microdissected 125 tumor and mesenchymal foci from I
S patient biopsies and analyzed the DNA for loss of heterozygosity usi
ng PCR microsatellite markers, In 100% of patients with genetic lesion
s on chromosome 8p, there was evidence for intra-tumoral genetic heter
ogeneity. There was also a low but significant incidence of loss of he
terozygosity in mesenchymal tissue, Our results show that phenotypical
ly similar tumor foci can have different genotypes and provide evidenc
e for the multifocality of tumor development in the prostate.